Raymond Simon, Favilla Ian, Santamaria Linda
Department of Surgery, Monash University, Victoria, Australia.
Invest Ophthalmol Vis Sci. 2009 Jun;50(6):2547-52. doi: 10.1167/iovs.08-3087. Epub 2009 Jan 24.
To determine whether intraocular lens (IOL) power calculations for cataract surgery as measured by postoperative refractive error using partial coherence interferometry (PCI) are more accurate in improving postoperative outcomes than applanation ultrasound biometry (AUS).
A double-blind randomized controlled trial consisting of 205 patients was undertaken by the Southern Health Ophthalmology Unit, Victoria, Australia. Mean absolute postoperative refractive error (MAE) represented the dependent variable; the biometric technique (PCI; AUS) used to determine the IOL power to be implanted in the surgical eye represented the independent variable. An intention-to-treat analysis was used to prevent loss of randomization caused by the effects of crossover and drop-out.
The MAE in patients with implanted PCI-calculated IOLs was 0.40 +/- 0.37 D (SD; 95% confidence interval [CI], 0.32-0.48 D) compared with 0.45 +/- 0.41 D (SD; 95% CI, 0.36-0.54 D) for patients with implanted AUS-calculated IOLs. There was no statistically significant difference between MAE in patients with implanted PCI-calculated IOLs and that in patients with AUS-calculated IOLs in analysis of best possible outcomes (t(167) = 1.0, P = 0.315).
The results of this trial demonstrated that the calculation of IOL power based on ocular axial length measurement with PCI technology provided no clinical advantage over conventional applanation ultrasound, as measured by postoperative refractive outcome (anzctr.org.au number, ACTRN12608000077369).
通过部分相干干涉测量法(PCI)使用术后屈光不正来确定白内障手术人工晶状体(IOL)屈光度计算在改善术后结果方面是否比压平式超声生物测量法(AUS)更准确。
澳大利亚维多利亚州南部健康眼科部门进行了一项由205名患者组成的双盲随机对照试验。平均绝对术后屈光不正(MAE)为因变量;用于确定手术眼中植入的IOL屈光度的生物测量技术(PCI;AUS)为自变量。采用意向性分析以防止因交叉和退出效应导致随机化的丧失。
植入PCI计算的IOL的患者的MAE为0.40±0.37 D(标准差;95%置信区间[CI],0.32 - 0.48 D),而植入AUS计算的IOL的患者的MAE为0.45±0.41 D(标准差;95%CI,0.36 - 0.54 D)。在分析最佳可能结果时,植入PCI计算的IOL的患者与植入AUS计算的IOL的患者的MAE之间无统计学显著差异(t(167) = 1.0,P = 0.315)。
该试验结果表明,通过术后屈光结果测量,基于PCI技术测量眼轴长度来计算IOL屈光度与传统压平式超声相比无临床优势(anzctr.org.au编号,ACTRN12608000077369)。